"In their own way, academic journals are exactly as selective as the tabloid health pages," claims the doctor and journalist Ben Goldacre in the Guardian newspaper on 20 September (http://tinyurl.com/4lyrq2). He writes that only 5.9% of industry sponsored trials on cancer treatment get published and that 75% had positive results. Doctors and academics need all data, positive and negative, to make fully informed decisions about treatment and the direction in which research should go. A comparison of all cancer trials registered in clinicaltrials.gov and published and indexed in PubMed found that only 17.6% of 2028 trials were published, 64.5% with positive results.
Comments